Todd Thomas, DO
Internal Medicine · Bartlesville, OKNPI 1891173555
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $7,453 of the $10,332 with a category attached, or 72.1%. It is spread thinly across 26 manufacturers, the largest accounting for just 22.5%. Among internal medicine clinicians in OK with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 232 payments — averaging $44.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$2K
- Abiomed$2K
- Boston Scientific$1K
- Abbott$795
- Inari Medical, Inc.$740
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$507
- plus $3K from 20 others
What the payments were for
- Grants$1,10511%
- Travel & lodging$1,12611%
- Food & beverage$7,45372%
- Education$6486%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 27 | $2,324 |
| Abiomed | 37 | $1,871 |
| Boston Scientific | 10 | $1,417 |
| Abbott | 18 | $795 |
| Inari Medical, Inc. | 15 | $740 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 42 | $507 |
| Philips North America LLC | 6 | $422 |
| E.r. Squibb & Sons, L.L.C. | 22 | $290 |
| Stryker | 5 | $282 |
| AstraZeneca | 7 | $250 |
| Penumbra, Inc. | 2 | $204 |
| Edwards Lifesciences | 2 | $183 |
| Cardiovascular Systems Inc. | 4 | $176 |
| Silk Road Medical, Inc. | 1 | $143 |
| Johnson & Johnson | 8 | $107 |
| Novartis | 7 | $104 |
| Lundbeck LLC | 1 | $100 |
| Terumo Medical Corporation | 5 | $86 |
| Boehringer Ingelheim | 3 | $84 |
| Amgen | 4 | $63 |
| GE HealthCare | 1 | $62 |
| Imperative Care, Inc | 1 | $46 |
| Innovation Technologies Inc | 1 | $27 |
| Biosense Webster, Inc. | 1 | $19 |
| Irhythm Technologies, Inc. | 1 | $18 |
| Regeneron Healthcare Solutions, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- RESOLUTE ONYX$1,160
- GENERAL - STRUCTURAL HEART$1,105
- Impella$783
- Resolute$280
- Ensite Cardiac Mapping System$263
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$161
- COREVALVE EVOLUT R$147
- ENROUTE Transcarotid Stent$143
- ENROUTE Transcarotid Neuroprotection System$143
- Indigo System$142
- Diamondback Coronary$124
- ARTIX MT$121
- (5153) Azurion 5 M20 GC$114
- (6391) Nexcimer$113
- FLOWTRIEVER CATHETER, S$110
- CT THROMBECTOMY SYSTEM KIT$110
- JETi Peripheral Catheter$102
- General - Balloon Catheters$102
How this compares
$10,332 in reported general payments places this provider in the 95th percentile of 840 internal medicine providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 101 | $89,718 |
| JardianceEmpagliflozin | 34 | $26,659 |
| XareltoRivaroxaban | 17 | $15,072 |
| EntrestoSacubitril/Valsartan | 18 | $12,388 |
| Ranolazine ErRanolazine | 53 | $3,051 |
| Atorvastatin Calcium | 148 | $1,882 |
| Rosuvastatin Calcium | 59 | $1,663 |
| ClopidogrelClopidogrel Bisulfate | 146 | $1,501 |
| Carvedilol | 139 | $895 |
| Metoprolol Succinate | 60 | $835 |
| Potassium Chloride | 40 | $655 |
| Pantoprazole Sodium | 38 | $429 |
| Chlorthalidone | 18 | $393 |
| Metoprolol Tartrate | 72 | $360 |
| Hydralazine Hcl | 16 | $351 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $84 | $26,65934 claims |
| Johnson & JohnsonXarelto | $107 | $15,07217 claims |
| NovartisEntresto | $104 | $12,38818 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 840 internal medicine providers in Oklahoma.
Other internal medicine in Bartlesville
- Steve EgwuonwuLawton$464K
- Jesse RichardsTulsa$279K
- Ryan MorganOklahoma City$235K
- Madhuri LadTulsa$173K
- Stacy ChronisterTulsa$163K
- Layth Al AttarTulsa$35K
- Ali JafryOklahoma City$33K
- Gerard McNultyTulsa$27K
- Yasir UsmanEnid$27K
- Peter LantzTulsa$23K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.